COVID Vax a Must at the Border; WHO to Rename Monkeypox; Abortions Rose in 2020

COVID Vax a Must at the Border; WHO to Rename Monkeypox; Abortions Rose in 2020 A daily roundup of news on COVID-19 and the rest of medicine Joyce Frieden medpagetoday

...

In standard-risk COVID-19 patients, nirmatrelvir/ritonavir (Paxlovid) failed to show a significant reduction in hospitalizations or death, with 5 events in the treatment arm and 10 in the placebo arm, Pfizer announced. Results were similar in a vaccinated subgroup...

...

Vaccinating everyone against monkeypox is likely unrealistic. (The Atlantic)...